Bronchodilator response during acute viral bronchiolitis in infancy.
Bronchodilator responsiveness was assessed by measuring specific respiratory conductance before and after inhalation of aerosolized bronchodilator in 50 infants who had acute bronchiolitis due to respiratory syncytial virus infection. Thirty per cent of the infants showed an improvement in specific conductance. Responders could not be differentiated from nonresponders by family histories of atopy, eosinophil counts, or immunoglobulin levels in blood and nasal secretions. Eighty-three per cent of the families and 54% of the mothers of the infants were smokers. Babies of smoking mothers had lower specific conductances than did those of nonsmoking mothers but showed no differences in bronchodilator response. The clinical significance of this bronchodilator-responsive sub-group has yet to be defined.
D000208:Acute Disease; D000420:Albuterol / Q000627:therapeutic use*; D000914:Antibodies, Viral / Q000032:analysis; D001942:Breast Feeding; D001990:Bronchiolitis, Viral / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D005260:Female; D006339:Heart Rate; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007073:Immunoglobulin E / Q000032:analysis; D007223:Infant; D008170:Lung Compliance; D008297:Male; D010290:Parents; D012115:Residual Volume; D012136:Respiratory Syncytial Viruses; D010253:Respirovirus Infections / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D012907:Smoking
D000914:Antibodies, Viral; D007070:Immunoglobulin A; D007073:Immunoglobulin E; D000420:Albuterol